Tongue paresthesia and dysgeusia following operative microlaryngoscopy.

Ann Otol Rhinol Laryngol

Department of Otolaryngology, The New York Eye and Ear Infirmary, New York, New York, USA.

Published: January 2006

Objectives: This study was performed to assess the overall incidence and duration of alterations in tongue sensation and taste after operative microlaryngoscopy, and the relation of these symptoms to operative time.

Methods: We performed a retrospective review of information regarding tongue symptoms in patients who completed standard post-microlaryngoscopy follow-up at 1 week, 1 month, and 3 months.

Results: One hundred patients (54 male and 46 female; mean age, 46 years; age range, 14 to 83 years) met the inclusion criteria. Eighteen patients had positive findings at 1 week: 15 complained of paresthesia and 3 of dysgeusia. The symptoms decreased over time without treatment (4% of patients at 1 month and 1% of patients at 3 months). Only 1 case of dysgeusia persisted past 3 months. Gender was found to be a significant independent risk factor for the development of symptoms (odds ratio, 5.63; 95% confidence interval, 1.36 to 31.29; p = .013). Patients whose operations lasted longer than 1 hour were almost 4 times more likely to develop tongue-related symptoms than those with an operative time less than 30 minutes, although these findings did not achieve statistical significance (odds ratio, 3.91; 95% confidence interval, 0.62 to 30.95; p = .182).

Conclusions: Alterations in tongue sensation and taste, most likely due to lingual nerve injury, are common after microlaryngoscopy, especially in female patients. They also tend to be associated with longer operative times. Although transient in nearly every case, lingual paresthesia and dysgeusia should form part of the preoperative discussion with the patient.

Download full-text PDF

Source
http://dx.doi.org/10.1177/000348940611500103DOI Listing

Publication Analysis

Top Keywords

paresthesia dysgeusia
12
operative microlaryngoscopy
8
alterations tongue
8
tongue sensation
8
sensation taste
8
symptoms operative
8
odds ratio
8
95% confidence
8
confidence interval
8
patients
7

Similar Publications

Article Synopsis
  • The study aimed to investigate how the intranasal drug zavegepant affects the pharmacokinetics of the oral contraceptive ethinyl estradiol and levonorgestrel (EE-LNG) when taken together.
  • It involved healthy females aged 18-45, who received a single dose of EE-LNG followed by multiple doses of zavegepant, with blood samples collected to analyze drug concentrations.
  • Results indicated minor and statistically insignificant changes in the levels of EE and LNG when zavegepant was co-administered, with some common side effects noted such as dysgeusia and throat irritation.
View Article and Find Full Text PDF

Treatment with Lu-prostate-specific membrane antigen (PSMA)-617 (Lu-vipivotide tetraxetan [Pluvicto]) prolongs both progression-free and overall survival in advanced PSMA-positive metastatic castration-resistant prostate cancer. Data examining specifically neurologic symptoms after Lu-PSMA-617 treatment are scarce. In this study, we aimed to review the neurologic findings in a large cohort of metastatic castration-resistant prostate cancer patients undergoing Lu-PSMA-617 therapy.

View Article and Find Full Text PDF

Oral manifestations of vitamin B12 deficiency associated with pernicious anemia: A case report.

Int J Surg Case Rep

August 2024

Department of Oral Surgery, Faculty of Dentistry, Mohammed V University, Morocco.

Article Synopsis
  • - Vitamin B12 deficiency can cause various oral issues like sore mouth, ulcers, and burning sensations, which may indicate underlying systemic conditions like pernicious anemia.
  • - A 67-year-old woman with a history of pernicious anemia presented with sore mouth and examined for oral lesions, revealing inflammation due to her condition; treatment included medication and laser therapy.
  • - Understanding the link between oral signs and vitamin B12 deficiency is essential for early diagnosis of pernicious anemia, prompting dental professionals to assess vitamin B12 levels in patients with unexplained oral symptoms.
View Article and Find Full Text PDF

Introduction: Magnetic resonance guided focused ultrasound (MRgFUS) thalamotomy is an effective treatment for drug-resistant tremor. The most frequent side effects are ataxia, gait disturbance, paresthesias, dysgeusia, and hemiparesis. Here, we report the first case of thalamic hand dystonia rapidly occurring after MRgFUS thalamotomy of the ventral intermediate nucleus (V.

View Article and Find Full Text PDF
Article Synopsis
  • Vernakalant is an intravenous anti-arrhythmic drug used for converting paroxysmal atrial fibrillation (AF) into sinus rhythm, but it is not FDA-approved due to safety concerns.
  • The study evaluated vernakalant's effectiveness and safety by focusing on patients with paroxysmal AF treated at the American University of Beirut Medical Center between 2015 and 2020.
  • Out of 23 patients, 61% achieved conversion to sinus rhythm within 90 minutes, with additional side effects like bradycardia reported in some cases.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!